Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.45 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.44 |
| ▸ | XBP1 | P17861 | 1/20 | 0.44 |
| ▸ | BTK | Q06187 | 2/20 | 0.44 |
| ▸ | KIT | P10721 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.41 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25144421 | 0.94 | PTGS1 (0.51) | MAPTNPSR1MEN1KMT2ANPC1 | |
| SCHEMBL25141315 | 0.89 | PTGS1 (0.52) | MAPTNPSR1MEN1KMT2ANPC1 | |
| SCHEMBL18720154 | 0.89 | MAPT (0.53) | MAPTNPSR1MEN1KMT2ANPC1 | |
| SCHEMBL25141380 | 0.88 | GLA (0.51) | NPC1RAB9APTGS1TRPV1 | |
| SCHEMBL26046283 | 0.87 | MAPT (0.49) | MAPTNPSR1MEN1KMT2ANPC1 | |
| SCHEMBL20089201 | 0.86 | MAPT (0.50) | MAPTNPSR1MEN1KMT2ANPC1 | |
| SCHEMBL18841444 | 0.86 | MAPT (0.50) | MAPTNPSR1MEN1KMT2ANPC1 | |
| SCHEMBL25143890 | 0.86 | PTGS1 (0.52) | MAPTMEN1KMT2ARAB9APTGS1 | |
| SCHEMBL25141347 | 0.84 | PTGS1 (0.50) | MAPTNPSR1MEN1KMT2ANPC1 | |
| SCHEMBL25143906 | 0.84 | PTGS1 (0.53) | MAPTNPSR1MEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230119106-A1 | Diamine Compound, Polyimide Precursor and Polyimide Prepared by Using the Same, Composition for Forming Polyimide Film and Polyimide Film Prepared by Using the Same, and Uses Thereof | SK INNOVATION CO., LTD. (KR) | 2023-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230119106-A1 | Diamine Compound, Polyimide Precursor and Polyimide Prepared by Using the Same, Composition for Forming Polyimide Film and Polyimide Film Prepared by Using the Same, and Uses Thereof | PUF60, WASF2, THEM6 | MAPT 748/4885NPSR1 4383/4885MEN1 950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.